Rhode Island Hospital part of national trial weighing benefits of COVID-19 plasma treatment

A CLINICAL TRIAL examining the use of blood plasma from patients who have had COVID-19 as a treatment for people with the virus is ongoing at Rhode Island Hospital. / COURTESY RHODE ISLAND HOSPITAL
PROVIDENCE – A clinical trial aimed at evaluating the effectiveness of treating COVID-19 patients with antibodies from others who have had or been exposed to the disease is ongoing at Rhode Island Hospital. The study, a collaboration between Rhode Island Hospital and Johns Hopkins University, is currently enrolling participants. The effort is part of a…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display